University of Pittsburgh researchers have identified new small molecules to promote AMP-activated Protein Kinase (AMPK) activity, a key regulator of several metabolic pathways. By discovering a key active site on AMPK, and subsequent computational screening of millions of compounds, a series of small molecules have been identified.